News Daily News FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom Michael O'Riordan February 09, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Conference News STS 2024 SAVR After Failed TAVI on the Rise, With High Mortality Yael L. Maxwell February 05, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details Michael O'Riordan January 25, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
Presentation Controversies and Advances 2023 Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward Presenter: Michael Mack November 30, 2023
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
News Conference News PCR London Valves 2023 For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE Shelley Wood November 20, 2023
News Conference News PCR London Valves 2023 Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway? Shelley Wood November 20, 2023
News Opinion Editor's Corner AHA 2023 What’s Going to Be Hot at AHA 2023 Shelley Wood November 07, 2023
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Daily News AHA Throws Its Support Behind New, Independent Medical Board Michael O'Riordan October 30, 2023
News Conference News TCT 2023 ‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II Michael O'Riordan October 26, 2023
Presentation TCT 2023 Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR) Presenter: Michael Reardon October 25, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
Presentation TCT 2023 Four-Year Outcomes From the EVOLUT Low Risk Trial Presenter: Michael Reardon October 24, 2023